Clinical Trials Logo

Clinical Trial Summary

When people undergo major surgery, they require intravenous supplementation of fluids for a number of reasons:

- to compensate for no oral intake

- to support blood pressure and organ function during and after surgery

- to replace lost fluid or blood volume

There are a variety of fluid choices doctors have to provide to patients, and it is still not definitively known whether some fluids are better than others in specific situations. This is a particularly interesting question in patients undergoing heart surgery because of the significant volume of fluids used over the entire course of hospitalization, including before the operation, during the operation, and after the operation.

There has been some scientific evidence that the use of starch-based fluids (synthetic colloids) leads to better oxygen delivery to the organs with a smaller volume of fluid given, providing for better recovery from surgery. However, there has also been some scientific evidence that the use of these fluids can harm kidney function. Importantly, none of these large-scale studies were carried out specifically in patients undergoing heart surgery.

The purpose of this study is to answer the question of whether the use of starch-based fluid in the heart surgery patient makes for a safer and faster recovery, causes kidney dysfunction, or makes no discernable difference.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT00964015
Study type Interventional
Source London Health Sciences Centre
Contact
Status Terminated
Phase N/A
Start date August 2009
Completion date June 2012

See also
  Status Clinical Trial Phase
Recruiting NCT05139108 - TEE Monitoring and the Incidence of Postoperative Acute Kidney Injury in Coronary Artery Bypass Grafting
Completed NCT04523064 - POST-CABGDM: Empagliflozin in Perioperative CABG Phase 4
Not yet recruiting NCT05540249 - Pre-operative Carbohydrates in Diabetic Patients Undergoing CABG N/A
Completed NCT01467232 - IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing Coronary Artery Bypass Grafting Phase 2
Completed NCT04631809 - Computed Tomography Coronary Angiography in Patients With a Previous Coronary Artery Bypass Graft Surgery Trial N/A
Completed NCT00073580 - Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE) Phase 3
Terminated NCT03346278 - Text Message Intervention to Improve Cardiac Rehab Participation N/A
Completed NCT00303641 - Safety and Effectiveness of the Medtronic Resting Heart Bypass System in Heart Surgery Patients Phase 1
Completed NCT03823521 - Observational Study to Investigate the Effects of Training on the Administration of Cardioplexolâ„¢ Phase 3
Terminated NCT00789399 - A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis N/A
Completed NCT02592824 - Glutamate for Metabolic Intervention in Coronary Surgery II Phase 3
Not yet recruiting NCT05079724 - Acute Kidney Injury After Cardiac Surgery
Withdrawn NCT04379947 - Preoperative Use of Fractional Flow Reserve in CABG Use and Effectiveness of FFR-based CABG in Real-life Practice
Terminated NCT00858936 - Reduction of Ischemia-Reperfusion Mediated Cardiac Injury in Subjects Undergoing Coronary Artery Bypass Graft Surgery Phase 2
Recruiting NCT01386229 - A Comparison of Etomidate and Ketamine for Anesthesia Induction in Coronary Artery Bypass Graft Surgery Phase 4
Completed NCT00653042 - Clinical Study to Evaluate Nesiritide in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery A014 / NAPA Phase 2
Completed NCT00318227 - Randomized Trial of a Liberal Versus a Restrictive Transfusion Strategy in Elderly Cardiac Surgery Patients N/A
Completed NCT00372671 - Evaluation of an Introductory Videotape Intervention to Improve Cardiac Rehabilitation Participation Phase 3
Completed NCT00209521 - Comparison of AQUAVAN® Injection to DISOPRIVAN® Injectable Emulsion for Anesthesia During Coronary Artery Surgery Phase 2
Not yet recruiting NCT05396690 - Safety and Efficacy of Remimazolam in OPCAB Surgery N/A